Literature DB >> 22042558

Characterization of Th1- and Th2-type immune response in human multidrug-resistant tuberculosis.

Q Tan1, W P Xie, R Min, G Q Dai, C-C Xu, H Q Pan, C D Miao, Z Yang, W G Xu, H Wang.   

Abstract

Multidrug-resistant tuberculosis (MDR-TB) has become a lethal global threat. Insights into the immune regulation of MDR-TB are urgently needed for the development of new treatments; however, the T cell response to an MDR-TB infection in human remains unclear. In the present study, the proportion of Th1 and Th2 cell subsets and the level of related T cell subset cytokines in peripheral blood were investigated. We detected that an MDR-TB infection resulted in suppressed Th1 and Th2 cell activation, which was more remarkable in patients with MDR-TB than that in drug-sensitive tuberculosis (DS-TB) sufferers when compared to healthy controls (HCs). In addition, MDR-TB infection down-regulated the expression of IFN-γ, IL-2, and IL-10, and up-regulated IL-4, IL-6, and TNF-α expression. Our data suggest that the disturbance between protective and pathogenic effects induced by the immunosuppression of Th1- and Th2-type responses is a substantial characteristic of MDR-TB infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042558     DOI: 10.1007/s10096-011-1434-4

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  43 in total

Review 1.  Immunology of tuberculosis.

Authors:  J L Flynn; J Chan
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 2.  Transcriptional regulation of Th1/Th2 polarization.

Authors:  J Rengarajan; S J Szabo; L H Glimcher
Journal:  Immunol Today       Date:  2000-10

3.  Clinical correlates of interferon gamma production in patients with tuberculosis.

Authors:  A Sodhi; J Gong; C Silva; D Qian; P F Barnes
Journal:  Clin Infect Dis       Date:  1997-09       Impact factor: 9.079

Review 4.  TNF in host resistance to tuberculosis infection.

Authors:  Valerie F J Quesniaux; Muazzam Jacobs; Nasiema Allie; Sergei Grivennikov; Sergei A Nedospasov; Irene Garcia; Maria L Olleros; Yuriy Shebzukhov; Dmitry Kuprash; Virginie Vasseur; Stephanie Rose; Nathalie Court; Rachel Vacher; Bernhard Ryffel
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

Review 5.  Advances in the immunopathogenesis of pulmonary tuberculosis.

Authors:  G A Rook; A Zumla
Journal:  Curr Opin Pulm Med       Date:  2001-05       Impact factor: 3.155

6.  Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis.

Authors:  R Hernández-Pando; H Orozcoe; A Sampieri; L Pavón; C Velasquillo; J Larriva-Sahd; J M Alcocer; M V Madrid
Journal:  Immunology       Date:  1996-09       Impact factor: 7.397

7.  Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma.

Authors:  Vijaya Nagabhushanam; Alejandra Solache; Li-Min Ting; Claire J Escaron; Jennifer Y Zhang; Joel D Ernst
Journal:  J Immunol       Date:  2003-11-01       Impact factor: 5.422

Review 8.  IL-23 and IL-17 in tuberculosis.

Authors:  Shabaana A Khader; Andrea M Cooper
Journal:  Cytokine       Date:  2008-01-22       Impact factor: 3.861

9.  Phenotypic and functional features of human Th17 cells.

Authors:  Francesco Annunziato; Lorenzo Cosmi; Veronica Santarlasci; Laura Maggi; Francesco Liotta; Benedetta Mazzinghi; Eliana Parente; Lucia Filì; Simona Ferri; Francesca Frosali; Francesco Giudici; Paola Romagnani; Paola Parronchi; Francesco Tonelli; Enrico Maggi; Sergio Romagnani
Journal:  J Exp Med       Date:  2007-07-16       Impact factor: 14.307

10.  Improving T-cell assays for the diagnosis of latent TB infection: potential of a diagnostic test based on IP-10.

Authors:  Morten Ruhwald; Janne Petersen; Kristian Kofoed; Hiroshi Nakaoka; Luis Eduardo Cuevas; Lovett Lawson; Stephen Bertil Squire; Jesper Eugen-Olsen; Pernille Ravn
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

View more
  9 in total

1.  Multifunctional T Cell Response to DosR and Rpf Antigens Is Associated with Protection in Long-Term Mycobacterium tuberculosis-Infected Individuals in Colombia.

Authors:  Leonar Arroyo; Mauricio Rojas; Kees L M C Franken; Tom H M Ottenhoff; Luis F Barrera
Journal:  Clin Vaccine Immunol       Date:  2016-10-04

2.  Sensitivity and specificity of the mean corpuscular volume and CD4/CD8 ratio in discriminating between rifampicin resistant and rifampicin sensitive tuberculosis.

Authors:  Joseph Baruch Baluku; Joseph Musaazi; Rose Mulwana; Derrick Bengo; Christine Sekaggya Wiltshire; Irene Andia-Biraro
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-11-23

3.  25(OH)D(3) affects the maturation and function of mouse bone marrow-derived dendritic cells stimulated by Mycobacterium bovis BCG.

Authors:  Hui-feng Yang; Ze-hua Zhang; Liang-bi Xiang; Kang-lai Tang; Fei Luo; Chun-yu Liu; Jian-bo Zhou; Jin-qing Li; Jian-zhong Xu
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

4.  The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis.

Authors:  Hong Shen; Rui Min; Qi Tan; Weiping Xie; Hong Wang; Hongqiu Pan; Li Zhang; Hongtao Xu; Xia Zhang; Jianzhong Dai
Journal:  Arch Med Sci       Date:  2015-06-19       Impact factor: 3.318

5.  Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis.

Authors:  Qi Tan; Rui Min; Guan-Qun Dai; Yan-Li Wang; Li Nan; Zhen Yang; Jun Xia; Shi-Yang Pan; Huang Mao; Wei-Ping Xie; Hong Wang
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

6.  A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.

Authors:  Selena Ferrian; Claudia Manca; Sugnet Lubbe; Francesca Conradie; Nazir Ismail; Gilla Kaplan; Clive M Gray; Dorothy Fallows
Journal:  PLoS One       Date:  2017-05-02       Impact factor: 3.240

7.  Plasma indoleamine 2,3-dioxygenase activity as a potential biomarker for early diagnosis of multidrug-resistant tuberculosis in tuberculosis patients.

Authors:  Wen Shi; Juan Wu; Qi Tan; Chun-Mei Hu; Xia Zhang; Hong-Qiu Pan; Zhen Yang; Meng-Yu He; Min Yu; Bo Zhang; Wei-Ping Xie; Hong Wang
Journal:  Infect Drug Resist       Date:  2019-05-14       Impact factor: 4.003

8.  A Group of Novel Serum Diagnostic Biomarkers for Multidrug-Resistant Tuberculosis by iTRAQ-2D LC-MS/MS and Solexa Sequencing.

Authors:  Chong Wang; Chang-Ming Liu; Li-Liang Wei; Li-Ying Shi; Zhi-Fen Pan; Lian-Gen Mao; Xiao-Chen Wan; Ze-Peng Ping; Ting-Ting Jiang; Zhong-Liang Chen; Zhong-Jie Li; Ji-Cheng Li
Journal:  Int J Biol Sci       Date:  2016-01-01       Impact factor: 6.580

9.  Increased Th1 Cells with Disease Resolution of Active Pulmonary Tuberculosis in Non-Atopic Patients.

Authors:  Chun-Yu Lo; Yu-Chen Huang; Hung-Yu Huang; Fu-Tsai Chung; Chang-Wei Lin; Kian Fan Chung; Chun-Hua Wang
Journal:  Biomedicines       Date:  2021-06-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.